HCA

SEC source: 0001209191-22-006080 · doc4.xml · derivative · entry 10

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 273 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 6

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,607

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 5

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-22-006080 · doc4.xml · derivative · entry 9

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273

Underlying: Common Stock · 272 shares

Expires 2029-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning January 30, 2022.

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 4

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,400

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-22-006080 · doc4.xml · derivative · entry 8

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 645

Underlying: Common Stock · 323 shares

Expires 2030-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning January 29, 2022.

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,201

SEC source: 0001209191-22-006080 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-22-006093 · doc4.xml · nonDerivative · entry 1

Smith Andrea B · CIK 0001649634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177

F1 · kind: Represents common stock underlying 177 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-22-006090 · doc4.xml · derivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

Underlying: Common Stock · 5,550 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006089 · doc4.xml · derivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 4,160 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006086 · doc4.xml · derivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,930

Underlying: Common Stock · 6,930 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006087 · doc4.xml · derivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

Underlying: Common Stock · 5,550 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006084 · doc4.xml · derivative · entry 5

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,950

Underlying: Common Stock · 24,950 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006083 · doc4.xml · derivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

Underlying: Common Stock · 5,550 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006082 · doc4.xml · derivative · entry 6

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,400

Underlying: Common Stock · 10,400 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006079 · doc4.xml · derivative · entry 1

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,480

Underlying: Common Stock · 12,480 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006080 · doc4.xml · derivative · entry 7

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

Underlying: Common Stock · 5,550 shares

Expires 2032-01-28

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 3

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,880

Underlying: Common Stock · 3,880 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.

F4 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning on January 28, 2023.

F4 · derivative.expiration_date: The restricted stock units vest in two equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 2

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,170

Underlying: Common Stock · 13,170 shares

Expires 2032-01-28

F2 · derivative.exercise_date: The stock appreciation rights vest in two equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 1

McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,860

Underlying: Common Stock · 13,860 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006075 · doc4.xml · derivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,630

Underlying: Common Stock · 86,630 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006073 · doc4.xml · derivative · entry 3

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,020

Underlying: Common Stock · 18,020 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006070 · doc4.xml · derivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,250

Underlying: Common Stock · 15,250 shares

Expires 2032-01-28

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006071 · doc4.xml · derivative · entry 1

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,020

Underlying: Common Stock · 18,020 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006068 · doc4.xml · derivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 4,160 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006067 · doc4.xml · derivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 4,160 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-006064 · doc4.xml · derivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,400

Underlying: Common Stock · 10,400 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.

SEC source: 0001209191-22-002235 · doc4.xml · derivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,375 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 3

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,879

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,357

F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.79, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-22-000339 · doc4.xml · derivative · entry 5

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,750 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-22-000339 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,555

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-22-000339 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,107

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 4

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Indirect · by 2021 Trust

Disclosed balance after: 4,000

SEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 3

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,878

SEC source: 0001209191-22-009467 · doc5.xml · nonDerivative · entry 2

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 7,877,331.0891

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F3 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 116,766 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 7,760,565.089138 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-22-009467 · doc5.xml · nonDerivative · entry 1

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia F. Elcan 2019 Annuity Trust II

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person is trustee of the Patricia F. Elcan 2019 Annuity Trust II and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules Holding II ("Hercules") held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 11

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.75 to $242.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 10

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.74 to $242.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 9

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,294

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.73 to $241.72, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,878

SEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Indirect · By PMP 2020 Trust

Disclosed balance after: 60,000

SEC source: 0001209191-21-063964 · doc4.xml · nonDerivative · entry 3

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,109.427

F1 · balance_after: Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-21-064279 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,524

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.1616 to $246.30, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-064277 · doc4.xml · derivative · entry 14

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,875 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-21-064277 · doc4.xml · derivative · entry 13

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.

SEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 8

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,294